Emyria CEO and MD, Dr. Michael Winlo, and new Independent Non-Executive Chairman, Mr. Greg Hutchinson, spoke with Andrew Scott at Proactive to discuss the Company’s innovative R&D program and plans for growth.
Emyria CEO and MD, Dr. Michael Winlo, and new Independent Non-Executive Chairman, Mr. Greg Hutchinson, spoke with Andrew Scott at Proactive to discuss the Company’s innovative R&D program and plans for growth.
If you have any question, please feel free to get in touch with us.